Anúncio
Anúncio

LUNG

LUNG logo

Pulmonx Corporation Common Stock

2.09
USD
Patrocinado
-0.12
-5.25%
08 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

2.12

+0.03
+1.43%

Relatórios de Lucros LUNG

Rácio de surpresa positiva

LUNG separação 20 de 21 últimas estimativas.

95%

Próximo Relatório

Data do Próximo Relatório
17 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$22.16M
/
-$0.39
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+3.07%
/
+14.71%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-6.74%
/
+18.18%

Pulmonx Corporation Common Stock earnings per share and revenue

On 12 de nov. de 2025, LUNG reported earnings of -0.34 USD per share (EPS) for Q3 25, beating the estimate of -0.42 USD, resulting in a 20.32% surprise. Revenue reached 21.50 milhão, compared to an expected 21.29 milhão, with a 1.02% difference. The market reacted with a -18.88% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analistas forecast an EPS of -0.39 USD, with revenue projected to reach 22.16 milhão USD, implying an aumentar of 14.71% EPS, and aumentar of 3.07% in Revenue from the last quarter.
FAQ
For Q3 2025, Pulmonx Corporation Common Stock reported EPS of -$0.34, beating estimates by 20.32%, and revenue of $21.50M, 1.02% above expectations.
The stock price moved down -18.88%, changed from $1.96 before the earnings release to $1.59 the day after.
The next earning report is scheduled for 17 de fev. de 2026.
Based on 8 analistas, Pulmonx Corporation Common Stock is expected to report EPS of -$0.39 and revenue of $22.16M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio